NCT06509945
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Peripheral T Cell Lymphoma
Explore clinical trials studying Peripheral T Cell Lymphoma. Study availability and eligibility vary by location and protocol.
52 public trials
24 recruiting studies
Peripheral T Cell Lymphoma trial results
NCT05675813
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Ruijin hospital Shanghai, Shanghai Municipality, China
NCT05444712
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Chu D'Amiens - Hopital Sud Amiens, France
- Chu D'Angers Angers, France
- Ch Victor Dupouy Argenteuil, France
- Ch D'Avignon - Hopital Henri Duffaut Avignon, France
Recruiting
Go-CHOP as the Frontline Therapy for PTCL
NCT05963347
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Henan Cancer Hospital Zhengzhou, Henan, China
Not Yet Recruiting
A Study of Bosmolisib (BR101801) in Participants With R/R PTCL.
NCT07180771
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified
Not Yet Recruiting
Combination Therapy With Tazemetostat in Relapsed and Refractory Peripheral T-cell Lymphoma
NCT07209163
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified
Not Yet Recruiting
Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)
NCT07032532
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China
Not Yet Recruiting
Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL)
NCT06712173
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified
Not Yet Recruiting
A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma
NCT06548347
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified
Not Yet Recruiting
(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)
NCT05923502
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Large B Cell Lymphoma, +27 more
- Locations
-
Not specified